AndrzejKudelkaMD

Oncology • Stony Brook, NY

Assistant Professor, Medicine, Stony Brook University SOM

Join to view full profile

Dr. Kudelka is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kudelka's full profile

Already have an account?

Office
3 Suny
# Z8151
Stony Brook, NY 11794
Phone+1 631-444-2540
Is this information wrong?

Education & Training

Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 1989 - 1990
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1987 - 1988
Coney Island HospitalResidency, Internal Medicine, 1984 - 1987
Medical University of GdanskClass of 1982

Certifications & Licensure

VA State Medical License 2021 - 2024
HI State Medical License 2019 - 2024
TX State Medical License 1990 - 2024
NY State Medical License 1988 - 2024
AZ State Medical License 2021 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2012-2014
Newsday - Top Doctors on Long Island Castle Connolly, 2012-2014
Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer Start of enrollment: 1998 Oct 01
Completed
Phase 2
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Jun 25
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2013 Jan 18
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Primitive neuroectodermal tumor of the uterus: Excellent clinical response following a multimodal treatment approach.
Adam Khorasanchi, Elizabeth Kertowidjojo, Sara Kim, W.M. Burke, Andrzej P. Kudelka> ;Gynecologic Oncology Reports. 2020 Feb 13
8 citations
The Chemoprevention of Ovarian Cancer: the Need and the Options.
Rishil J. Kathawala, Andrzej P. Kudelka, Basil Rigas> ;Current Pharmacology Reports. 2018 May 2
Correction: The Chemoprevention of Ovarian Cancer: the Need and the Options.
Rishil J. Kathawala, Andrzej P. Kudelka, Basil Rigas> ;Current Pharmacology Reports. 2018 Sep 10
5 citations
Merkel Cell Carcinoma With Gastric Metastasis and Review of Literature
Zishuo Ian Hu, Jessica A. Schuster, Andrzej P. Kudelka, Tara L. Huston> ;Journal of Cutaneous Medicine and Surgery. 2016 May 1
28 citations
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors
Claire F. Verschraegen, Keith M. Skubitz, Adil Daud, Andrzej P. Kudelka, Ian Rabinowitz, Cecilia Allievi, Amy J. Eisenfeld, Jack W. Singer, Fred B. Oldham> ;Cancer Chemotherapy and Pharmacology. 2009 Apr 1
3 citations
Optimal modeling for phase I design of a two drug combination-results of a phase I study of cisplatin with 9-nitrocamptothecin.
S.-J. Lee, Murugesan Gounder, Eric H. Rubin, Jong Ming Li, Zheming Gu, A. Thalasila, Evelyne M. Loyer, Andrzej P. Kudelka, Claire F. Verschraegen> ;Investigational New Drugs. 2008 Jul 4
272 citations
Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis
Shenhong Wu, John J. Chen, Andrzej Kudelka, Janice Lu, Xiaolei Zhu> ;Lancet Oncology. 2008 Feb 1
49 citations
Optimism, distress, health-related quality of life, and change in cancer antigen 125 among patients with ovarian cancer undergoing chemotherapy.
Janet S. de Moor, Carl de Moor, Karen Basen-Engquist, Andrzej P. Kudelka, Michael W. Bevers, Lorenzo Cohen> ;Psychosomatic Medicine. 2006 Jul 1
39 citations
The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer
Patricia A. Parker, Andrzej P. Kudelka, Karen Basen-Engquist, John J. Kavanagh, Janet S. de Moor, Lorenzo Cohen> ;Gynecologic Oncology. 2006 Mar 1
1 citations
Phase II Study of Intravenous DX‐8951f in Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer Refractory to Platinum, Taxane, and Topotecan
Claire F. Verschraegen, C. Levenback, Monique Vincent, Judith K. Wolf, Michael W. Bevers, Evelyne M. Loyer, Andrzej P. Kudelka, John J. Kavanagh> ;Annals of the New York Academy of Sciences. 2006 Jan 25
3 citations
Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies.
Claire F. Verschraegen, Monique Vincent, James L. Abbruzzese, D. Siegler, John J. Kavanagh, Evelyne M. Loyer, Andrzej P. Kudelka, Eric H. Rubin> ;Annals of the New York Academy of Sciences. 2006 Jan 25
34 citations
Retrospective review: re‐treatment of patients with ovarian cancer with carboplatin after platinum resistance
Hui Ti See, Ralph S. Freedman, Andrzej P. Kudelka, Thomas W. Burke, David M. Gershenson, Siriwan Tangjitgamol, John J. Kavanagh> ;International Journal of Gynecological Cancer. 2005 Mar 1
11 citations
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer ...
Claire F. Verschraegen, Andrzej P. Kudelka, Wei Hu, Monique Vincent, John J. Kavanagh, Evelyne M. Loyer, Luc Bastien, A. Duggal, R. De Jager> ;Cancer Chemotherapy and Pharmacology. 2004 Jan 1
26 citations
Physiological and psychological effects of delivering medical news using a simulated physician-patient scenario.
Lorenzo Cohen, Walter F. Baile, Evelyn M. Henninger, Sandeep K. Agarwal, Andrzej P. Kudelka, Renato Lenzi, Janet Sterner, Gailen D. Marshall> ;Journal of Behavioral Medicine. 2003 Oct 1
37 citations
Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor.
Wei Hu, Wei Guo Wu, Claire F. Verschraegen, Ling Chen, Li Mao, Sai Ching Jim Yeung, Andrzej P. Kudelka, Ralph S. Freedman, John J. Kavanagh> ;Proteomics. 2003 Oct 1
34 citations
Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer
Claire F. Verschraegen, Silke Westphalen, Wei Hu, Evelyne M. Loyer, Andrzej P. Kudelka, Peter Völker, John J. Kavanagh, Melissa Steger, Klaus Dieter Schulz, Günter Emons> ;Gynecologic Oncology. 2003 Sep 1
7 citations
Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12.
Bohuslav Melichar, Renato Lenzi, Michael G. Rosenblum, Andrzej P. Kudelka, John J. Kavanagh, Karolina Melicharová, Stacie Templin, Michael E. Garcia, James L. Abbruzze...> ;Journal of Immunotherapy. 2003 May 1
33 citations
Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers
Claire F. Verschraegen, Wei Hu, Yu Du, John Mendoza, Janet Early, Michael T. Deavers, Ralph S. Freedman, Robert C. Bast, Andrzej P. Kudelka, John J. Kavanagh, Beppino ...> ;Clinical Cancer Research. 2003 Feb 1
33 citations
An in vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines
Michael L Leblanc, Jennifer Russo, Andrzej P. Kudelka, Judith A. Smith> ;Pharmacological Research. 2002 Dec 1
61 citations
Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma
Renato Lenzi, Michael Rosenblum, Claire F. Verschraegen, Andrzej P. Kudelka, John J. Kavanagh, Marshall E. Hicks, Eric A. Lang, Michael A. Nash, Lawrence B. Levy, Mich...> ;Clinical Cancer Research. 2002 Dec 1
7 citations
Thiotepa in combination with cisplatin for primary epithelial ovarian cancer: a phase II study.
M. E. Gordinier, Andrzej P. Kudelka, John J. Kavanagh, Wharton Jt, Ralph S. Freedman> ;International Journal of Gynecological Cancer. 2002 Nov 1
116 citations
Toxicity, Immunogenicity, and Induction of E75-specific Tumor-lytic CTLs by HER-2 Peptide E75 (369–377) Combined with Granulocyte Macrophage Colony-stimulating Factor ...
James L. Murray, Michael E. Gillogly, Donna Przepiorka, Hannah Brewer, Nuhad K. Ibrahim, Daniel J. Booser, Gabriel N. Hortobagyi, Andrzej P. Kudelka, Kenneth H. Grabst...> ;Clinical Cancer Research. 2002 Nov 1
23 citations
Induction of Tumor-Reactive CTL by C-Side Chain Variants of the CTL Epitope HER-2/neu Protooncogene (369-377) Selected by Molecular Modeling of the Peptide: HLA-A2 Com...
Agapito Castilleja, Darrick Carter, Clay L. Efferson, Nancy E. Ward, Kouichiro Kawano, B Fisk, Andrzej P. Kudelka, David M. Gershenson, James L. Murray, Catherine A. O...> ;Journal of Immunology. 2002 Oct 1
3 citations
Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro.
Agapito Castilleja, Nancy E. Ward, Richard B. Epstein, Andrzej P. Kudelka, David M. Gershenson, Clay L. Efferson, Catherine A. O'Brian, Constantin G. Ioannides> ;Oncology Reports. 2002 Sep 1
4 citations
Activity of ALRT 1550, a new retinoid, with interferon-γ on ovarian cancer cell lines
Wei Hu, Claire F. Verschraegen, W. Wu, M Nash, Ralph S. Freedman, Andrzej P. Kudelka, John J. Kavanagh> ;International Journal of Gynecological Cancer. 2002 Mar 1
Join now to see all

Press Mentions

Andrzej Kudelka, MD, FACP, FACE, Is Recognized by Continental Who's WhoMarch 19th, 2022
Andrzej Kudelka, MD, FACP, FACE, Is Recognized by Continental’s Who’s WhoMarch 19th, 2022